Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin J Pain. 2008 Feb;24(2):93-7. doi: 10.1097/AJP.0b013e31815ca2b4.

Buprenorphine: new tricks with an old molecule for pain management.

Author information

1
Department of Medicine, Georgetown School of Medicine, Fairfax, VA 22031, USA. howard204@aol.com

Erratum in

  • Clin J Pain. 2008 May;24(4):370.

Abstract

Sublingual buphrenorphine is a unique opioid medication based on its pharmacokinetics and pharmacodynamic properties. It may be used "on label" as an alternative choice to methadone for the treatment of opioid addiction or "off-label" for the treatment of both acute and chronic pain. Because of high mu receptor affinity and resultant blockade, it has been suggested that this might interfere with the management of moderate to severe pain in patients on opioid agonist treatment. The following article will offer strategies and approaches to address some of these real and perceived challenges.

PMID:
18209513
DOI:
10.1097/AJP.0b013e31815ca2b4
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Support Center